AB
PBYI icon

Amalgamated Bank’s Puma Biotechnology PBYI Stock Holding History

Amalgamated Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,353
Closed -$8K – 2483
2025
Q4 		$8K Sell
1,353
-79
-6% -$420 ﹤0.01% 2533
2025
Q3 		$8K Hold
1,432
– – ﹤0.01% 2568
2025
Q2 		$5K Hold
1,432
– – ﹤0.01% 2775
2025
Q1 		$4K Hold
1,432
– – ﹤0.01% 2736
2024
Q4 		$4K Hold
1,432
– – ﹤0.01% 2799
2024
Q3 		$4K Hold
1,432
– – ﹤0.01% 2835
2024
Q2 		$5K Buy
+1,432
New +$6.29K ﹤0.01% 2786
2022
Q2 		– Sell
-5,256
Closed -$15K – 3158
2022
Q1 		$15K Buy
+5,256
New +$13.6K ﹤0.01% 2884
2018
Q3 		– Sell
-4,438
Closed -$263K – 1570
2018
Q2 		$263K Buy
4,438
+536
+14% +$31.1K 0.01% 1405
2018
Q1 		$266K Sell
3,902
-8
-0.2% -$599 0.01% 1284
2017
Q4 		$387K Buy
3,910
+254
+7% +$28.4K 0.01% 1125
2017
Q3 		$438K Sell
3,656
-31
-0.8% -$2.88K 0.01% 1011
2017
Q2 		$322K Buy
+3,687
New +$206K 0.01% 1151
2016
Q1 		– Sell
-2,726
Closed -$214K – 1305
2015
Q4 		$214K Sell
2,726
-198
-7% -$15.5K 0.03% 1021
2015
Q3 		$220K Buy
2,924
+44
+2% +$4.16K 0.02% 1090
2015
Q2 		$336K Buy
2,880
+406
+16% +$73.5K 0.03% 876
2015
Q1 		$584K Buy
2,474
+207
+9% +$44.3K 0.07% 349
2014
Q4 		$429K Buy
2,267
+3
+0.1% +$666 0.07% 404
2014
Q3 		$540K Buy
+2,264
New +$465K 0.08% 318
2014
Q2 		– Sell
-2,391
Closed -$249K – 899
2014
Q1 		$249K Buy
2,391
+95
+4% +$11.2K 0.04% 660
2013
Q4 		$238K Buy
+2,296
New +$135K 0.04% 675

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Amalgamated Bank's PBYI Position: Q1 2026 in Review

Amalgamated Bank sold out of Puma Biotechnology (PBYI) in Q1 2026, closing a stake of 1,353 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in PBYI in Q4 2013 and held it in 21 quarters. The position peaked at $584K in Q1 2015. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Amalgamated Bank reported no remaining Puma Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,353 Puma Biotechnology shares in Q1 2026, an estimated $8K.
  • Amalgamated Bank first reported a position in Puma Biotechnology in Q4 2013 and held it in 21 quarters.
  • Amalgamated Bank's Puma Biotechnology position peaked at $584K in Q1 2015.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.